From Recommendation to Vaccination: Improving Shingles Vaccine Uptake in Internal Medicine (2026 AC Live)

Only available as part of a package

This educational activity is supported by an independent medical education grant from GSK.

Learning Objectives:

Apply current ACIP recommendations for recombinant zoster vaccine (RZV) to consistently identify adults aged ≥50 years and immunocompromised adults aged ≥19 years who are eligible for vaccination during routine clinical care and chronic disease management.
Implement evidence-based vaccine communication strategies, including strong presumptive recommendations, risk framing, and motivational interviewing techniques, to effectively address shingles vaccine hesitancy and improve patient acceptance of RZV.
Integrate workflow and team-based strategies to improve completion of the two-dose RZV series, including scheduling, reminder/call systems, and patient counseling on vaccine safety and expected reactogenicity, in alignment with CDC guidance.

Mia A. Taormina, DO, FACOI (she/her/hers)

Chair, Department of Infectious Disease

Duly Health and Care

Chair, Department of Infectious Disease - Duly Health and Care
Director, Clinical Board of Directors - Duly Health and Care
Co-Chair, Infectious Disease Subsection - American College of Osteopathic Internists
Adjunct Clinical Faculty - Midwestern University - Chicago College of Osteopathic Medicine

The faculty member, for this activity, has no relevant relationships with ineligible companies to disclose.